May 31 (Reuters) - Mylan Laboratories Inc. MYL.N said it received U.S. regulatory approval for Azithromycin tablets, a generic version of Pfizer's (PFE.N) antibiotic Zithromax.
The approval is for dosages of 250 mg and 500 mg, and Azithromycin tablets had U.S. sales of about $886 million for the 12 months ending March 31, 2007, for the same strengths, Mylan said in a statement. (Reporting by Jennifer Robin Raj in Bangalore)
COPENHAGEN (Reuters) - U.N. climate talks avoided a total collapse on Saturday by skirting bitter opposition from several nations to a deal championed by the U.S. President Barack Obama and five emerging economies including China. | Video
On the last day of every month, shoppers at Walmart load their carts with food and household items and wait for the midnight hour. Is this the new normal in America? Full Article
The battered M&A sector will make a tepid recovery in the coming year and three hot sectors will lead the way, according to a Thomson Reuters analysis. Full Article
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
